Browsing Tag
Heart Rhythm Society
4 posts
Medtronic expands cardiac ablation ambitions as Sphere-9 gains FDA Breakthrough Device pathway for VT
Medtronic’s Affera push is no longer just an AFib story. VT data may decide whether Sphere-9 becomes a broader ablation platform.
Abbott (NYSE: ABT) showcases four HRS 2026 trials as cardiac rhythm market competition intensifies
Abbott has fresh arrhythmia data, but its stock sits near yearly lows. Can cardiac innovation reset investor confidence?
Abbott’s Volt PFA system delivers strong 12-month AFib outcomes, heart rhythm society 2025 data reveal
Explore how Abbott’s Volt™ PFA System is redefining AFib treatment with groundbreaking 12-month results — see why it’s a game-changer in cardiac care.
Medtronic’s next-generation Affera technologies strengthen innovation in atrial fibrillation care
Find out how Medtronic’s Affera™ system is redefining atrial fibrillation care with breakthrough pulsed field ablation technologies. Read the full update!